Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Caffeic acid phenylethyl ester

HIV-1 integrase inhibitor
ALX-270-244-M010 10 mg 31.00 USD
ALX-270-244-M050 50 mg 71.00 USD
Replaces Prod. #: BML-FR102

Active component of propolis from honeybee hives, known to have anti-mitogenic, anti-carcinogenic, anti-inflammatory, and immunomodulatory properties. Potent and specific inhibitor of NF-κB activation, induced by TNF-α (Prod. No. ALX-522-008 (human) or Prod. No. ALX-522-009 (mouse)), PMA (Prod. No. BML-PE160) and other inflammatory agents. Exhibits inhibitory activity against HIV-1 integrase (IC50=7µM). Suppresses lipid peroxidation and inhibits ornithine decarboxylase, protein tyrosine kinase and lipoxygenase activities. Induces apoptosis.

Product Specification

Alternative Name:CAPE, Phenethyl caffeiate, Caffeic acid phenethyl ester
Purity:≥97% (HPLC)
Appearance:White to off-white crystalline solid.
Solubility:10mg/ml soluble in DMSO, 100% ethanol, methanol, acetone or acetonitrile; insoluble in water.
Long Term Storage:-20°C
Use/Stability:Stable for at least one year after receipt when stored at -20°C.
Handling:Protect from light and moisture.
Please mouse over

Product Literature References

Drastic effect of several caffeic acid derivatives on the induction of heme oxygenase-1 expression revealed by quantitative real-time RT-PCR: K. Suzuki, et al.; Biofactors 28, 151 (2006), Abstract;
Caffeic acid derivatives: in vitro and in vivo anti-inflammatory properties: F.M. da Cunha, et al.; Free Radic. Res. 38, 1241 (2004), Abstract;
Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors: N. Marquez, et al.; J. Pharmacol. Exp. Ther. 308, 993 (2004), Abstract;
Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation: Z. Orban, et al.; Neuroimmunomodulation 7, 99 (2000), Abstract;
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation: P. Michaluart, et al.; Cancer Res. 59, 2347 (1999), Abstract;
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B: K. Natarajan, et al.; PNAS 93, 9090 (1996), Abstract;
Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells: C. Chiao, et al.; Cancer Res. 55, 3576 (1995), Abstract;
Hydroxylated aromatic inhibitors of HIV-1 integrase: T.R. Burke Jr., et al.; J. Med. Chem. 38, 4171 (1995), Abstract;

Related Products

Caffeic acid 

Lipoxygenase inhibitor
331-39-5, Synthetic., ≥97% (HPLC) | Print as PDF
ALX-270-231-G001 1 g 30.00 USD

Caffeic acid ethyl ester 

66648-50-8, Synthetic., ≥97% (GC) | Print as PDF
ALX-270-480-M050 50 mg 30.00 USD
ALX-270-480-M250 250 mg 60.00 USD

TNF-α (soluble) (human), (recombinant) 

Produced in E. coli. The extracellular domain of human TNF-α (tumor necrosis factor-α) (aa 85-223) is fused at the N-terminus to a linker peptide (8 aa) and a FLAG®-tag., ≥95% (SDS-PAGE), ELISA | Print as PDF
ALX-522-008-C050 50 µg 307.00 USD

TNF-α (soluble) (mouse), (recombinant) 

Produced in E. coli. The extracellular domain of mouse TNF-α (tumor necrosis factor-α) (aa 77-235) is fused at the N-terminus to a linker peptide (8 aa) and a FLAG®-tag., ≥90% (SDS-PAGE), ELISA | Print as PDF
ALX-522-009-C050 50 µg 309.00 USD

Phorbol 12-myristate 13-acetate 

PKC activator
16561-29-8, ≥99% (HPLC, TLC) | Print as PDF
BML-PE160-0001 1 mg 51.00 USD
BML-PE160-0005 5 mg 121.00 USD

Related Literature

Product Flyers
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage 18-Jul-13
Download as PDF

Scientific Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling 20-Sep-10
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2015 Enzo Life Sciences, Inc.,